AHA Scientific Sessions 2026 Abstract

Vessel lining cells show more damage in progeria mice

Restoring vessel-lining function was linked to better liver and kidney function and longer lifespan in mice modeling the premature-aging disorder.

Paper by Weifeng Qin · Houston Methodist
Blood vessel cutaways show a gapped lining beside a closely joined lining, with a laboratory mouse and a dark ring nearby.
Studied:
Experiments in HGPS mice, against VSMCs
What changed:
DNA damage, telomere erosion, and senescence markers were more pronounced in vessel lining cells than in vessel muscle cells
The catch:
The conference abstract gives no mouse group sizes, treatment dose, or lifespan effect size

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Mice modeling Hutchinson-Gilford progeria syndrome had more DNA damage, erosion of chromosome ends and signs of senescence—a state in which cells stop dividing—in blood-vessel lining cells than in vessel muscle cells. The laboratory experiments also used a three-dimensional system combining these cell types from people with progeria or unaffected individuals.

In that system, progeria lining cells disrupted the vessel barrier and induced senescence in normal vascular cells; progeria muscle cells did not. Restoring telomerase, an enzyme that maintains chromosome ends, specifically in lining cells restored the integrity of the model vessel’s inner channel. Targeting muscle cells had minimal effects. In mice, delivery throughout the body of ring-shaped RNA carrying instructions for telomerase reduced inflammatory activation and senescence in small liver and kidney vessels.

Why it matters

Progeria causes premature cardiovascular death. The authors suggest considering therapies aimed at the vessel lining for progeria and other forms of blood vessel aging.

Caveats

The results came from mice and a lab-grown cell system, not from treating people with progeria. The conference abstract gives no mouse group sizes, treatment dose or size of the lifespan effect.

Comments

Be the first to comment.